Vimarsana
Biggest News Aggregation in the World

Jeff Coller News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jeff Coller. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jeff Coller Today - Breaking & Trending Today

Johns Hopkins to establish new RNA innovation center in collaboration with TriLink BioTechnologies - Vimarsana News

Johns Hopkins to establish new RNA innovation center in collaboration with TriLink BioTechnologies

The center, anchored in the Institute for NanoBioTechnology, will speed the cycle of RNA innovation in pursuit of advanced therapies

Source: jhu.edu
Hope for haploinsufficiency diseases | Popular Science - Vimarsana News

Hope for haploinsufficiency diseases | Popular Science

Genetic conditions like Dravet syndrome are hard to tackle with traditional gene therapy. But new approaches are in the works.

Source: popsci.com
Tevard Biosciences announces collaboration with Vertex to develop novel tRNA-based therapies for Duchenne muscular dystrophy - Vimarsana News

Tevard Biosciences announces collaboration with Vertex to develop novel tRNA-based therapies for Duchenne muscular dystrophy

/PRNewswire/ -- Tevard Biosciences, Inc., the pioneer of tRNA-based therapies for severe genetic diseases, today announced a four-year global research...

Tevard Biosciences Appoints Zoya Ignatova to Its Scientific Advisory Board - Vimarsana News

Tevard Biosciences Appoints Zoya Ignatova to Its Scientific Advisory Board

/PRNewswire/ -- Tevard Biosciences, the pioneer of tRNA-based therapies for severe genetic diseases, today announced the appointment of leading tRNA scientist...

Tevard Biosciences licenses mRNA Amplifier technology from Johns Hopkins University - Vimarsana News

Tevard Biosciences licenses mRNA Amplifier technology from Johns Hopkins University

/PRNewswire/ -- Tevard Biosciences, the pioneer of tRNA-based treatments for severe genetic diseases, today announced an agreement to exclusively license "mRNA...